418 related articles for article (PubMed ID: 25003670)
1. Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management.
Başaranoğlu M; Örmeci N
Turk J Gastroenterol; 2014 Apr; 25(2):127-32. PubMed ID: 25003670
[TBL] [Abstract][Full Text] [Related]
2. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Sugimoto K; Inui H; Fukusato T
World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
[TBL] [Abstract][Full Text] [Related]
3. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
4. Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.
Corey KE; Rinella ME
Dig Dis Sci; 2016 May; 61(5):1387-97. PubMed ID: 26942734
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Syndrome: Nonalcoholic Fatty Liver Disease.
Williams T
FP Essent; 2015 Aug; 435():24-9. PubMed ID: 26280342
[TBL] [Abstract][Full Text] [Related]
6. Modern approach to the clinical management of non-alcoholic fatty liver disease.
Del Ben M; Polimeni L; Baratta F; Pastori D; Loffredo L; Angelico F
World J Gastroenterol; 2014 Jul; 20(26):8341-50. PubMed ID: 25024593
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D; Schattenberg JM
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
[TBL] [Abstract][Full Text] [Related]
8. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease: a challenge for pediatricians.
Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
[TBL] [Abstract][Full Text] [Related]
10. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
Clemente MG; Mandato C; Poeta M; Vajro P
World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
[TBL] [Abstract][Full Text] [Related]
11. The diagnosis and treatment of non-alcoholic fatty liver disease.
Altinbas A; Sowa JP; Hasenberg T; Canbay A
Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
[TBL] [Abstract][Full Text] [Related]
12. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
13. [An Overview of NAFLD/NASH in Japan].
Kim SR; Kim KI
Yakugaku Zasshi; 2016; 136(4):565-72. PubMed ID: 27040340
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
Carr RM; Oranu A; Khungar V
Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease - current status and future directions.
Demir M; Lang S; Steffen HM
J Dig Dis; 2015 Oct; 16(10):541-57. PubMed ID: 26406351
[TBL] [Abstract][Full Text] [Related]
16. Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Golabi P; Bush H; Younossi ZM
Clin Liver Dis; 2017 Nov; 21(4):739-753. PubMed ID: 28987260
[TBL] [Abstract][Full Text] [Related]
17. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
Younossi ZM
Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
[TBL] [Abstract][Full Text] [Related]
18. A Critical Approach of Guideline Therapeutic Recommendations for NAFLD.
Djordjevic DB; Zdravkovic M; Nagorni A; Manolis A; Tsioufis C; Lovic D
Curr Vasc Pharmacol; 2018; 16(3):228-238. PubMed ID: 28676026
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease: Synopsis of current developments.
Onyekwere CA; Ogbera AO; Samaila AA; Balogun BO; Abdulkareem FB
Niger J Clin Pract; 2015; 18(6):703-12. PubMed ID: 26289505
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic Fatty Liver Disease--The Clinician's Perspective.
Agrawal S; Duseja A
Trop Gastroenterol; 2014; 35(4):212-21. PubMed ID: 26349165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]